openFDA
Cure8 regulatory brief
Prednisone FDA label update (2026-07-13)
Medications
Prednisone
Corticosteroids
Steroids
Regulatory Update
Adult patients
Clinicians
Pregnant Patients
Why This Matters
The FDA/DailyMed label defines approved uses and official dosing guidance for prednisone, a corticosteroid commonly used to treat moderate-to-severe inflammatory conditions including ulcerative colitis and regional enteritis (Crohn’s disease).
Changes or clarifications to the label can affect prescribing and patient counseling.
Who Should Pay Attention
Adult patients with ulcerative colitis or Crohn’s disease considering or already on prednisone; clinicians who prescribe corticosteroids; pregnant patients who may need corticosteroid therapy.
Study Snapshot
Story typeRegulatory
Evidence typeRegulatory update
Study statusHuman prescription drug
Source depthRegulatory record
What To Know
The document is the official drug label for prednisone and summarizes when prednisone may be used, recommended dosing ranges, and cautions about abrupt stopping and individualized dosing. It notes GI irritation management, morning dosing to reduce adrenal suppression, and that higher or lower doses may be used depending on disease severity.
For IBD the label lists ulcerative colitis and regional enteritis among gastrointestinal indications.
Keep In Mind
This record is a regulatory drug-label document (DailyMed/FDA). It summarizes indications, dosing, and precautions but is not a clinical trial report. For personalized treatment decisions, consult your clinician. If pregnant, discuss fetal and maternal risk with your provider.
Source Details
Review the original publication for the complete reporting, methods, and context.
Regulatory update
Evidence type derived from source or registry metadata.
PublicationopenFDA
PublisherU.S. Food and Drug Administration
SponsorBryant Ranch Prepack
Study typeDrug Label Update
Indexed viaopenFDA
Source typeRegulatory record
PublishedJul 13, 2026, 12:00 AM
Content availableRegulatory record
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Dexamethasone FDA label update (2026-07-07)
This is the FDA DailyMed label for dexamethasone, which lists gastrointestinal uses including short-term use in ulcerative colitis and regional enteritis (Crohn's disease). Patients with IBD may be prescribed...
Understanding role of microbiota in Crohn's disease, ulcerative colitis
The article explains how gut bacteria may contribute to IBD and summarizes common tests and treatments people are likely to encounter. It highlights emerging microbial therapies (probiotics and FMT) that some patients...
Large Vessel Vasculitis in IBD Linked to Younger Onset, Distinct Clinical Features
This study suggests LVV can occur in people with IBD at younger ages and with distinct vascular findings, and it may arise even when gut disease is in remission. That matters for awareness, diagnosis, and coordination...